Hyponatremia and Hypernatremia: Key Concepts and Management (Notes)
Hyponatremia overview
Hyponatremia = low serum sodium, typically < 135 mEq/L. Severity and symptoms depend on acuity and rate of change.
Hyponatremia always involves excess total body water relative to sodium; where the excess resides (intracellular vs extracellular compartments) and the body’s volume status determine the clinical picture.
Key distinction: total body water excess versus sodium balance. In all hypotonic hyponatremias there is a relative water excess, but the distribution (hypovolemic, euvolemic, hypervolemic) changes management and physiology.
The risk spectrum ranges from asymptomatic to life-threatening brain edema (encephalopathy) with rapid correction potential causing central pontine myelinolysis if mishandled.
Pathophysiology and kinds of hyponatremia
General principle: the body’s total body water (TBW) is increased relative to sodium in hyponatremia, but where the water accumulates vs. where sodium is retained varies.
SIADH (syndrome of inappropriate antidiuretic hormone secretion): a common euvolemic hyponatremia.
Features: high ADH with water retention, concentrated urine, continued urine output but low free water excretion.
Urine findings: urine osmolality elevated; urine sodium often elevated due to natriuresis and euvolemia.
Concept: kidney reabsorbs water despite hyponatremia; kidneys are not failing; the problem is excess ADH activity.
Hypervolemic hyponatremia: total body water is disproportionately increased relative to sodium, seen in edema-forming states.
Examples: congestive heart failure, cirrhosis, nephrotic syndrome.
Paradox: intravascular volume can be depleted or effectively low despite edema; RAAS and ADH are activated, promoting water and sodium retention in ways that can worsen hyponatremia.
Urine sodium: typically low if aldosterone is effectively promoting sodium reabsorption; in CKD, urine sodium may be higher due to damaged tubules.
Hypovolemic hyponatremia: low total body water with disproportionate sodium loss; often from diuresis, GI losses, or adrenal insufficiency.
Mechanism that ties these together: in states with perceived low intravascular volume, the body activates ADH to retain water, which can worsen hyponatremia even when total body water is high.
Na+/water balance considerations:
Aldosterone status (RAAS) matters: low aldosterone can predispose toward hyponatremia with high urine Na; high aldosterone can promote sodium retention, potentially limiting urine Na in some states.
Medications, osmotic agents, or diseases can mimic or drive hyponatremia (e.g., SIADH, hypothyroidism, pain/nausea, certain antidepressants, anticonvulsants).
Signs and symptoms of hyponatremia
Symptoms depend on acuity and sodium level:
Acute/severe cases: more pronounced neurologic symptoms; risk of brain edema and herniation.
Chronic hyponatremia (progressing over days-weeks) may be better tolerated as brain cells adapt to hypoosmolality but remains dangerous if corrected too quickly.
Common presentations by severity:
Sodium < 125 mEq/L: admission commonly considered; symptoms may be present or absent depending on acuity.
Mild hyponatremia (≈130–135 mEq/L): may be asymptomatic or have mild symptoms.
Moderate symptoms: confusion, nausea, malaise; lethargy, decreased muscle tone, tremors may appear.
Severe hyponatremia (≈110–115 mEq/L or lower): cerebral edema risk, seizures, coma, brainstem herniation.
Special caution: body can adapt to gradual changes; rapid correction is dangerous due to risk of osmotic demyelination syndrome.
Initial clinical approach and targets in hyponatremia management
Admit if sodium is under 125 mEq/L, especially if symptomatic or if there are signs of cerebral involvement.
In asymptomatic patients with chronic hyponatremia, management may be outpatient with careful monitoring; the clinician weighs symptoms, labs, medications, and hydration status.
In acute symptomatic hyponatremia or severe neurological symptoms: emergency correction with hypertonic saline in ICU settings rules apply.
General principle: slow and controlled correction to avoid osmotic demyelination syndrome; target a safe initial correction before reassessment.
Hypervolemic hyponatremia: management principles
Primary goal: reduce total body water while preserving or restoring intravascular volume.
Approach:
Fluid restriction to limit further water intake.
Loop diuretics (e.g., furosemide) to promote free water excretion and sodium excretion; cautious use to avoid hypovolemia.
In selected cases, vasopressin receptor antagonists (ADH antagonists) may be used to promote free water excretion without solute loss.
Monitor urine output, serum Na, and urine osmolality to guide therapy.
Hypovolemic hyponatremia: management principles
Primary therapy: restore intravascular volume with isotonic saline (normal saline).
Rationale: increasing intravascular volume suppresses ADH release, reducing free water retention and aiding sodium correction.
If severe symptoms persist or saline is insufficient, hypertonic saline may be considered in ICU following protocol.
Continuous monitoring with serial serum sodium and urine osmolality is essential.
Euvolemic hyponatremia (often SIADH) management
Treat underlying cause (e.g., stopping offending drugs, addressing infections, managing pituitary/hypothalamic issues).
Fluid restriction is a mainstay.
Consider ADH antagonists if ongoing free water retention persists despite fluid restriction.
In severe cases with symptoms, hypertonic saline may be used with careful monitoring to avoid rapid correction.
Severe hyponatremia: hypertonic saline and inpatient management
Indications for hypertonic saline (e.g., 3% NaCl): unconsciousness, seizures, significant brain edema, or life-threatening symptoms.
Administration principles (typical in many programs; exact protocols vary by institution):
Bolus initial dosing (e.g., 100 mL of 3% NaCl over 10 minutes) may be used to rapidly raise Na in patients with severe symptoms, then reassess.
Alternatively, continuous infusion at a controlled rate (often 50–100 mL/hour of 3% NaCl) with frequent labs every 4 hours.
Target initial correction to about 120–125 mEq/L in severely symptomatic patients, then slow further correction toward 135–145 mEq/L as symptoms stabilize.
If there is ongoing cerebral edema or seizures, consider bolus therapy and, if necessary, ICU admission for advanced monitoring.
Mannitol can be used to support cerebral edema while sodium correction proceeds.
Switching strategies: once initial goals are achieved (e.g., Na around 125–130 mEq/L and symptoms improve), some patients may be transitioned from hypertonic saline to isotonic saline or other fluids as guided by labs and hemodynamics.
Safety and decision-making in hyponatremia management
Gray areas exist; treatment requires inpatient judgment, especially for severe cases and those with comorbidities.
Rapid correction carries risk of osmotic demyelination syndrome; slow and steady correction is emphasized.
Formulas help guide therapy, but real-time reassessment is essential.
Calculations and formulas used in hyponatremia management
Total body water (TBW):
Note: 60% of body weight is water in the average adult.
Sodium deficit (to restore sodium from current Na to target Na):
Example: if Nadesired = 140, Naact = 120, and weight = 70 kg; then TBW = $70 imes 0.6 = 42$ L; deficit = $42 imes (140 - 120) = 42 imes 20 = 840$ mEq.
Free water deficit (to achieve Natarget from Naactual):
One common form (to get a positive deficit when Naactual < Natarget):
A more intuitive form that yields a positive value is:
Note: Na_target is typically 140 mEq/L when applying these formulas.
Maximum correction rate for hyponatremia (in many protocols):
Acute correction limit: up to
For a patient of weight W (kg), the maximum hourly rise in Na is roughly
Example calculation (case from transcript): patient 70 kg, maximum rate 2 mEq/kg/hr → max rate =
If the total sodium deficit is 294 mEq, time to correction at max rate ≈
Acute vs chronic correction guidelines mentioned:
Chronic hyponatremia: do not correct faster than ≈ 10 mEq/L in the first 24 hours.
Acute hyponatremia: can be corrected more rapidly, up to about 1–2 mEq/L per hour, with careful monitoring.
Hypertonic saline dosing reference from transcript:
Initial rate often 50–100 mL/hour (3% NaCl) with possible paralytic bolus if indicated by the clinical scenario.
Bolus doses (e.g., 100 mL) may be used in severe neurologic symptoms; then reassess and adjust to avoid overshoot.
Other therapeutic options mentioned:
Loop diuretics to reduce total body water in hypervolemic hyponatremia and to facilitate free water excretion.
ADH antagonists to block water reabsorption in cases of inappropriate ADH activity.
Hypertonic saline in ICU for severe symptomatic hyponatremia or seizures.
Mannitol to help reduce intracranial pressure as sodium is corrected.
Hypernatremia: overview, causes, and management (brief)
Hypernatremia = elevated serum sodium, usually with hyperosmolar state.
Common scenario: hypovolemia with free water loss (dehydration), often with dry mucous membranes, hypotension, and high urine osmolality as the kidneys try to conserve water.
Pathophysiology: in most cases, increased serum Na is accompanied by high serum osmolality; urine osmolality is typically high as the kidneys concentrate urine to conserve water.
Other scenarios: diabetes insipidus, osmotic diuresis, excessive sodium intake, or iatrogenic factors.
Management principles:
Restore intravascular volume first if hypovolemic to improve perfusion and kidney function.
Correct hypernatremia gradually to avoid cerebral edema. Typical correction is slower (not faster than a few tenths of a mEq/L per hour in many protocols), with close monitoring of serum Na and clinical status.
Address underlying cause (impaired thirst, diabetes insipidus, fever/heat loss, diuretic use, etc.).
Urine findings help differentiate etiologies: high urine osmolality suggests concentrated urine (kidneys are holding water), whereas low urine osmolality suggests diabetes insipidus or water loss with intact renal water excretion.
Practical connections and implications
Clinical decision-making in hyponatremia/hypernatremia is highly nuanced and patient-specific; many decisions depend on volume status, symptom severity, and rapidity of onset.
Ethical/practical implications: balancing rapid correction to relieve life-threatening symptoms with the risk of osmotic demyelination; the need to avoid harm from both under-treatment (ongoing brain edema) and over-treatment (rapid Na correction causing demyelination).
Connection to foundational physiology: the RAAS system, ADH/vasopressin axis, and renal handling of water and solutes are central to understanding both hyponatremia and hypernatremia.
The transcript emphasizes that real-world management has gray areas and often requires inpatient, multidisciplinary care (PA/MD input, ICU monitoring, tailored fluid therapy).
Worked case study intuition (from the transcript)
Example patient: unconscious with severe hyponatremia (Na ≈ 118 mEq/L) and hypotension.
Initial goals: rapid stabilization and prevention of brain injury; target Na around 120–125 mEq/L as a cautious first step.
Hypertonic saline indicated due to severe symptoms and CNS involvement.
In the scenario described, an initial hypertonic bolus was used, then rate adjustments were made to move toward a safe correction while monitoring neurologic status and labs.
The nurses/physicians discussed calculating the deficit and rate: using TBW and per-hour max correction, then determining how long to infuse hypertonic saline to reach the initial target before switching to isotonic saline or other therapies.
Calculation recap from the scenario:
Weight = 70 kg → TBW =
If initial target Na = 125 mEq/L and current Na = 118 mEq/L: deficit ≈
Max rate for correction:
Time to correct 294 mEq at 140 mEq/h ≈ 2.1 hours (rounded to 2–3 hours depending on patient response and safety).
Takeaway: the math underpins a planned, monitored correction strategy rather than a one-size-fits-all solution.
Summary caution notes for exam-style understanding
Fast correction is dangerous; the aim is to move toward a safe, stable sodium level and symptom resolution without overshoot.
Always consider volume status first and tailor fluids accordingly (hypovolemia, euvolemia, hypervolemia).
Use the TBW-based formulas to estimate deficits and plan infusion rates, but rely on frequent labs (serum Na, serum osmolality, urine osmolality, urine Na) to guide stepwise adjustments.
Recognize the different management pathways for hyponatremia vs hypernatremia and the special considerations in conditions like SIADH, CKD, heart failure, cirrhosis, and nephrotic syndrome.